Dr. Shakeel Modak, MBBS

NPI: 1063483535
Total Payments
$109,015
2024 Payments
$2,175
Companies
6
Transactions
16

Payment Breakdown by Category

Other$98,605 (90.5%)
Consulting$10,230 (9.4%)
Travel$101.65 (0.1%)
Food & Beverage$77.89 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Grant $98,500 2 90.4%
Consulting Fee $10,230 6 9.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $105.00 2 0.1%
Travel and Lodging $101.65 2 0.1%
Food and Beverage $77.89 4 0.1%

Top Paying Companies

Company Total Records Latest Year
Genentech, Inc. $98,500 2 $0 (2020)
Y-mAbs Therapeutics, Inc. $3,050 3 $0 (2022)
USWM, LLC $2,689 3 $0 (2022)
Progenics Pharmaceuticals, Inc. $2,541 5 $0 (2019)
EMD Serono Research & Development Institute, Inc. $2,130 1 $0 (2024)
Partner Therapeutics, Inc. $105.00 2 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $2,175 2 EMD Serono Research & Development Institute, Inc. ($2,130)
2023 $60.00 1 Partner Therapeutics, Inc. ($60.00)
2022 $3,939 4 USWM, LLC ($2,689)
2021 $1,800 2 Y-mAbs Therapeutics, Inc. ($1,800)
2020 $48,500 1 Genentech, Inc. ($48,500)
2019 $2,541 5 Progenics Pharmaceuticals, Inc. ($2,541)
2018 $50,000 1 Genentech, Inc. ($50,000)

All Payment Transactions

16 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
09/23/2024 EMD Serono Research & Development Institute, Inc. Consulting Fee Cash or cash equivalent $2,130.00 General
01/05/2024 Partner Therapeutics, Inc. LEUKINE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $45.00 General
Category: Hematology/Oncology
12/28/2023 Partner Therapeutics, Inc. LEUKINE (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $60.00 General
Category: Hematology/Oncology
03/28/2022 Y-mAbs Therapeutics, Inc. DANYELZA (Drug) Consulting Fee Cash or cash equivalent $1,250.00 General
Category: ONCOLOGY
03/04/2022 USWM, LLC Consulting Fee Cash or cash equivalent $2,650.00 General
03/03/2022 USWM, LLC Food and Beverage In-kind items and services $22.99 General
02/20/2022 USWM, LLC Food and Beverage In-kind items and services $15.97 General
10/07/2021 Y-mAbs Therapeutics, Inc. DANYELZA (Drug) Consulting Fee Cash or cash equivalent $1,300.00 General
Category: ONCOLOGY
07/09/2021 Y-mAbs Therapeutics, Inc. Consulting Fee Cash or cash equivalent $500.00 General
07/31/2020 Genentech, Inc. Grant Cash or cash equivalent $48,500.00 General
04/10/2019 Progenics Pharmaceuticals, Inc. Consulting Fee Cash or cash equivalent $2,400.00 General
04/10/2019 Progenics Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $28.00 General
03/20/2019 Progenics Pharmaceuticals, Inc. Travel and Lodging In-kind items and services $73.65 General
02/25/2019 Progenics Pharmaceuticals, Inc. Food and Beverage In-kind items and services $3.57 General
02/22/2019 Progenics Pharmaceuticals, Inc. Food and Beverage In-kind items and services $35.36 General
06/15/2018 Genentech, Inc. Grant Cash or cash equivalent $50,000.00 General

About Dr. Shakeel Modak, MBBS

Dr. Shakeel Modak, MBBS is a Pediatrics healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063483535.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shakeel Modak, MBBS has received a total of $109,015 in payments from pharmaceutical and medical device companies, with $2,175 received in 2024. These payments were reported across 16 transactions from 6 companies. The most common payment nature is "Grant" ($98,500).

Practice Information

  • Specialty Pediatrics
  • Location New York, NY
  • Active Since 01/31/2006
  • Last Updated 04/26/2012
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1063483535

Products in Payments

  • DANYELZA (Drug) $2,550
  • LEUKINE (Drug) $105.00

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in New York